Business Trends– category –
-
Global Perovskite Surge: China’s 3GW Factory, Korea’s Space Cells, and INFICON’s Precision Drive Commercialization
Perovskite-Info China, South Korea, イタリア, Germany Overview Global efforts to commercialize perovskite solar cells are accelerating rapidly. China is set to complete a 3GW module manufacturing base by October 2026, while South Korea's... -
T-CURX Acquires Germany’s Pantherna Therapeutics to Accelerate LNP-Based In Vivo CAR-T Therapy Development; United Immunity Also Enters In Vivo CAR-M Therapy for Solid Tumors and Fibrotic Diseases
HealthcareNOWradio.com Germany Overview T-CURX acquired Germany-based Pantherna Therapeutics, specializing in mRNA engineering and lipid nanoparticle (LNP) delivery technology, aiming to accelerate in vivo CAR-T therapy development and c... -
20th World Drug Delivery Summit in London in June to Focus on Nanoparticle DDS Market Trends, Investment Opportunities, and Clinical Trials
Conference Series UK Overview The 20th World Drug Delivery Summit, held in London on June 8-9, 2026, will focus on how nanoparticles, including liposomes, micelles, and polymeric nanoparticles, enhance drug efficacy and targeted delivery... -
Cartesian Therapeutics Licenses WestGene LNP Technology, Initiates Phase 1 for In Vivo CAR-T Descartes-08 in Myasthenia Gravis, Streamlining Manufacturing
Biospace USA Overview Cartesian Therapeutics announced a strategic licensing agreement with WestGene Biopharma to accelerate its in vivo CAR-T platform development using WestGene’s targeted lipid nanoparticle (LNP) technology. This colla... -
China’s Prinano Achieves Mass Production of 8-inch Photonic Chips with Proprietary Nanoimprint Tech, Bypassing ASML Equipment, Reducing Cost by 10x, and Achieving Sub-10nm Resolution to Circumvent Export Controls
South China Morning Post China Overview Chinese startup Prinano announced successful mass production of photonic chips on 8-inch silicon wafers using its proprietary PL-AS vacuum air-cushion nanoimprint lithography (NIL) equipment, elimi... -
FDA Endorses ‘Prior Knowledge’ Use in Gene Therapy Development, Streamlining Review for AAV, Nanoparticle Delivery Systems, and Cell Therapies
Hogan Lovells USA Overview The U.S. Food and Drug Administration (FDA) issued guidance endorsing the use of 'Prior Knowledge' in the development of genome editing products, a policy expected to streamline drug development and review proc... -
First Graphene Acquires US-Based MITO Material Solutions for Up to $850K, Bolstering Functional Graphene Products and US Market Presence
Proactive Investors Australia Overview Australia's First Graphene has signed an agreement to acquire the assets, intellectual property, product lines, and manufacturing capabilities of US-based MITO Material Solutions for up to $850,000.... -
Cosmos Health Subsidiary Cana Laboratories Acquires International Patent WO2025108566A1, Expanding Nanotechnology Investment to Accelerate Next-Gen Healthcare Product Development
Stock Titan USA Overview Cosmos Health announced that its wholly-owned subsidiary, Cana Laboratories S.A., has acquired international patent application WO2025108566A1 from Cloudpharm P.C., significantly expanding its nanotechnology inve... -
Bioinspired Adiposomes Deliver Docetaxel to Lung, Multiple Myeloma, and Hepatocellular Carcinoma with Reduced Systemic Toxicity and Equivalent Efficacy
bioRxiv USA Overview Researchers have developed biocompatible adiposome nanoparticles for targeted delivery of the hydrophobic anticancer drug docetaxel (DTX), demonstrating significantly reduced systemic toxicity while maintaining equiv... -
CombiCult® Screening Platform Establishes Feeder-Free Bioreactor Scalability for iPSC-Derived NK Cell Manufacturing
Frontiers (Preprint) Germany Overview This preprint reports research developing a feeder-free protocol for generating mature, functional iPSC-derived natural killer (iNK) cells using the high-throughput combinatorial screening platform C...
